Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 4
2001 2
2002 3
2003 2
2004 2
2005 4
2006 3
2007 4
2008 5
2009 5
2010 2
2011 2
2012 13
2013 11
2014 11
2015 15
2016 12
2017 15
2018 17
2019 17
2020 41
2021 60
2022 52
2023 54
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Interstitial lung disease 2"
Page 1
Pulmonary rehabilitation for interstitial lung disease.
Dowman L, Hill CJ, May A, Holland AE. Dowman L, et al. Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4. Cochrane Database Syst Rev. 2021. PMID: 34559419 Free PMC article. Review.
BACKGROUND: Interstitial lung disease (ILD) is characterised by reduced functional capacity, dyspnoea and exercise-induced hypoxia. ...We specified a priori subgroup analyses for participants with idiopathic pulmonary fibrosis (IPF) and participants with seve …
BACKGROUND: Interstitial lung disease (ILD) is characterised by reduced functional capacity, dyspnoea and exercise-indu …
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D. Hellmich B, et al. Ann Rheum Dis. 2024 Jan 2;83(1):30-47. doi: 10.1136/ard-2022-223764. Ann Rheum Dis. 2024. PMID: 36927642
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN. Barnes H, et al. Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2. Cochrane Database Syst Rev. 2018. PMID: 29297205 Free PMC article. Review.
BACKGROUND: Approximately one-third of individuals with interstitial lung disease (ILD) have associated connective tissue disease (CTD). ...When appropriate, we performed meta-analyses and subgroup analyses by severity of lung function, connecti …
BACKGROUND: Approximately one-third of individuals with interstitial lung disease (ILD) have associated connective tiss …
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M; joint committee of Japanese Respiratory Society and Japan College of Rheumatology. Kondoh Y, et al. Respir Investig. 2021 Nov;59(6):709-740. doi: 10.1016/j.resinv.2021.04.011. Epub 2021 Oct 1. Respir Investig. 2021. PMID: 34602377 Review.
The prognosis of patients with connective tissue disease (CTD) has improved significantly in recent years, but interstitial lung disease (ILD) associated with connective tissue disease (CTD-ILD) remains a refractory condition, which is a leading …
The prognosis of patients with connective tissue disease (CTD) has improved significantly in recent years, but interstitial …
JAK inhibitors and systemic sclerosis: A systematic review of the literature.
Moriana C, Moulinet T, Jaussaud R, Decker P. Moriana C, et al. Autoimmun Rev. 2022 Oct;21(10):103168. doi: 10.1016/j.autrev.2022.103168. Epub 2022 Aug 6. Autoimmun Rev. 2022. PMID: 35944611 Review.
A significant cutaneous response (decrease in the mRSS - modified Rodnan skin score - of >5 points and 25% from baseline) was reported in 52 patients (88%). Among patients with interstitial lung disease (ILD) (n = 31), 28/29 patients had no ILD progression …
A significant cutaneous response (decrease in the mRSS - modified Rodnan skin score - of >5 points and 25% from baseline) was reported in …
Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review.
Paik JJ, Lubin G, Gromatzky A, Mudd PN Jr, Ponda MP, Christopher-Stine L. Paik JJ, et al. Clin Exp Rheumatol. 2023 Mar;41(2):348-358. doi: 10.55563/clinexprheumatol/hxin6o. Epub 2022 Jun 28. Clin Exp Rheumatol. 2023. PMID: 35766013 Free PMC article. Review.
In patients with adult DM complicated by interstitial lung disease (ILD; n=33), 31 (94%) patients improved with JAK inhibitor treatment. ...Four patients with JDM and ILD experienced improvement in lung disease activity following treatment with …
In patients with adult DM complicated by interstitial lung disease (ILD; n=33), 31 (94%) patients improved with JAK inh …
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review.
Abuhelwa Z, Alloghbi A, Alqahtani A, Nagasaka M. Abuhelwa Z, et al. Drugs. 2022 Jun;82(9):979-987. doi: 10.1007/s40265-022-01736-w. Epub 2022 Jun 27. Drugs. 2022. PMID: 35759121 Free PMC article.
Interstitial lung disease/pneumonitis events were treated with a dose interruption or reduction, treatment discontinuation, corticosteroids, and supportive care. CONCLUSIONS: Interstitial lung disease/pneumonitis is a well-described, seri …
Interstitial lung disease/pneumonitis events were treated with a dose interruption or reduction, treatment discontinuat …
Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review.
Bohannon RW, Crouch R. Bohannon RW, et al. J Eval Clin Pract. 2017 Apr;23(2):377-381. doi: 10.1111/jep.12629. Epub 2016 Sep 4. J Eval Clin Pract. 2017. PMID: 27592691 Review.
Inclusion necessitated that articles (1) be original, full length, and peer reviewed, (2) report an MCID for the 6MWT, and (3) focus on adults with medical issues. ...The populations studied included people with chronic obstructive pulmonary disease, lung can …
Inclusion necessitated that articles (1) be original, full length, and peer reviewed, (2) report an MCID for the 6MWT, and (3) focus …
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
Teel A, Lu J, Park J, Singh N, Basharat P. Teel A, et al. Semin Arthritis Rheum. 2022 Dec;57:152088. doi: 10.1016/j.semarthrit.2022.152088. Epub 2022 Aug 31. Semin Arthritis Rheum. 2022. PMID: 36116345 Review.
OBJECTIVE: To evaluate the role of myositis-specific autoantibodies (MSAs) in interstitial lung disease (ILD), management of idiopathic inflammatory myopathies (IIM) associated ILD, and if there is a role for MSA specific management of ILD. ...The most common …
OBJECTIVE: To evaluate the role of myositis-specific autoantibodies (MSAs) in interstitial lung disease (ILD), manageme …
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Yan M, Louie AV, Kotecha R, Ashfaq Ahmed M, Zhang Z, Guckenberger M, Kim MS, Lo SS, Scorsetti M, Tree AC, Sahgal A, Slotman BJ. Yan M, et al. Lung Cancer. 2023 Aug;182:107281. doi: 10.1016/j.lungcan.2023.107281. Epub 2023 Jun 21. Lung Cancer. 2023. PMID: 37393758 Free article.
BACKGROUND: Stereotactic body radiotherapy (SBRT) is an effective and safe modality for early-stage lung cancer and lung metastases. However, tumors in an ultra-central location pose unique safety considerations. ...There were 73 treatment related deaths, with a poo …
BACKGROUND: Stereotactic body radiotherapy (SBRT) is an effective and safe modality for early-stage lung cancer and lung metas …
335 results